These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9604126)

  • 21. The Lack of Effect of Food on the Pharmacokinetics of ZX008 (Fenfluramine Oral Solution): Results of a Single-dose, Two-period Crossover Study.
    Gammaitoni A; Smith S; Boyd B
    Clin Ther; 2018 Aug; 40(8):1338-1346. PubMed ID: 29941151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and food interaction of MK-462 in healthy males.
    Cheng H; Polvino WJ; Sciberras D; Yogendran L; Cerchio KA; Christie K; Olah TV; McLoughlin D; James I; Rogers JD
    Biopharm Drug Dispos; 1996 Jan; 17(1):17-24. PubMed ID: 8991488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of high-fat breakfast and moderate-fat evening meal on the pharmacokinetics of vardenafil, an oral phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction.
    Rajagopalan P; Mazzu A; Xia C; Dawkins R; Sundaresan P
    J Clin Pharmacol; 2003 Mar; 43(3):260-7. PubMed ID: 12638394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-dependent pharmacokinetics and brain penetration of rufinamide following intravenous and oral administration to rats.
    Gáll Z; Vancea S; Szilágyi T; Gáll O; Kolcsár M
    Eur J Pharm Sci; 2015 Feb; 68():106-13. PubMed ID: 25530452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral bioavailability of ospemifene improves with food intake.
    Koskimies P; Katila K; Lammintausta R; Aaltonen AM; Vuorinen J; Saarni O; Scheinin M
    Int J Clin Pharmacol Ther; 2013 Oct; 51(10):787-94. PubMed ID: 24040848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized phase I study to evaluate the safety, tolerability, pharmacokinetics and food-effect of Iguratimod in healthy adult volunteers.
    Xiao F; Zhang F; Zhang LL; Wei W
    Eur J Clin Pharmacol; 2018 Jan; 74(1):69-77. PubMed ID: 29051989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pharmacokinetic study of two modified-release methylphenidate formulations under different food conditions in healthy volunteers.
    Haessler F; Tracik F; Dietrich H; Stammer H; Klatt J
    Int J Clin Pharmacol Ther; 2008 Sep; 46(9):466-76. PubMed ID: 18793577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of licarbazepine in healthy volunteers: single and multiple oral doses and effect of food.
    Souppart C; Gardin A; Greig G; Balez S; Batard Y; Krebs-Brown A; Appel-Dingemanse S
    J Clin Pharmacol; 2008 May; 48(5):563-9. PubMed ID: 18258749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of food on the bioavailability of a carbamazepine slow-release formulation.
    Retzow A; Schürer M; Schulz HU
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):557-60. PubMed ID: 9455713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of food on the oral bioavailability of loratadine and pseudoephedrine from extended-release tablets in healthy volunteers.
    Nomeir AA; Mojaverian P; Kosoglou T; Affrime MB; Nezamis J; Rodwanski E; Lin CC; Cayen MN
    J Clin Pharmacol; 1996 Oct; 36(10):923-30. PubMed ID: 8930779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of food intake on the pharmacokinetics of avosentan in man.
    Dieterle W; Hengelage T
    Int J Clin Pharmacol Ther; 2008 Sep; 46(9):453-8. PubMed ID: 18793575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral absorption kinetics of levetiracetam: the effect of mixing with food or enteral nutrition formulas.
    Fay MA; Sheth RD; Gidal BE
    Clin Ther; 2005 May; 27(5):594-8. PubMed ID: 15978308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of food intake on the pharmacokinetic properties of mirabegron oral controlled-absorption system: a single-dose, randomized, crossover study in healthy adults.
    Lee J; Zhang W; Moy S; Kowalski D; Kerbusch V; van Gelderen M; Sawamoto T; Grunenberg N; Keirns J
    Clin Ther; 2013 Mar; 35(3):333-41. PubMed ID: 23497763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic profile of a 24-hour controlled-release OROS formulation of hydromorphone in the presence and absence of food.
    Sathyan G; Xu E; Thipphawong J; Gupta SK
    BMC Clin Pharmacol; 2007 Feb; 7():2. PubMed ID: 17270055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of food intake on the pharmacokinetics of diclofenac potassium soft gelatin capsules: a single-dose, randomized, two-way crossover study.
    Scallion R; Moore KA
    Clin Ther; 2009 Oct; 31(10):2233-41. PubMed ID: 19922894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of food intake on the pharmacokinetics and antidiuretic activity of oral desmopressin (DDAVP) in hydrated normal subjects.
    Rittig S; Jensen AR; Jensen KT; Pedersen EB
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):235-41. PubMed ID: 9579238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the Pharmacokinetics of the Phase II and Phase III Capsule Formulations of Selumetinib and the Effects of Food on Exposure: Results From Two Randomized Crossover Trials in Healthy Male Subjects.
    Tomkinson H; McBride E; Martin P; Lisbon E; Dymond AW; Cantarini M; So K; Holt D
    Clin Ther; 2017 Nov; 39(11):2260-2275.e1. PubMed ID: 28985960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rufinamide: a double-blind, placebo-controlled proof of principle trial in patients with epilepsy.
    Pålhagen S; Canger R; Henriksen O; van Parys JA; Rivière ME; Karolchyk MA
    Epilepsy Res; 2001 Feb; 43(2):115-24. PubMed ID: 11164700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of food on cabergoline pharmacokinetics and tolerability in healthy volunteers.
    Persiani S; Rocchetti M; Pacciarini MA; Holt B; Toon S; Strolin-Benedetti M
    Biopharm Drug Dispos; 1996 Jul; 17(5):443-55. PubMed ID: 8830979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of food on the bioavailability of dolasetron mesylate tablets.
    Lippert C; Keung A; Arumugham T; Eller M; Hahne W; Weir S
    Biopharm Drug Dispos; 1998 Jan; 19(1):17-9. PubMed ID: 9510981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.